Free Trial
NYSE:OGEN

Oragenics (OGEN) Stock Price, News & Analysis

$1.06
+0.03 (+2.40%)
(As of 10:58 AM ET)
Today's Range
$1.01
$1.07
50-Day Range
$0.99
$3.09
52-Week Range
$0.97
$7.74
Volume
96,285 shs
Average Volume
106,784 shs
Market Capitalization
$4.77 million
P/E Ratio
N/A
Dividend Yield
N/A
Price Target
N/A
OGEN stock logo

About Oragenics Stock (NYSE:OGEN)

Oragenics, Inc., a development-stage company, engages in the research and development of antibiotics for infectious diseases in the United States. The company engages in the development and commercialization of NT-CoV2-1, an intranasal vaccine candidate that provides immunity from the novel severe acute respiratory syndrome coronavirus. The company's product candidates also comprise LPT3-04, a weight loss candidate; and SMaRT Replacement Therapy, a topical treatment to prevent dental carries. It has a license agreement with Noachis Terra Inc. for licensing of certain specified patent rights and biological materials relating to the use of pre-fusion coronavirus spike proteins; and a collaboration agreement ILH Holdings, Inc. for the development and commercialization of MU1140 and related homologs. The company was formerly known as Oragen, Inc. Oragenics, Inc. was incorporated in 1996 and is headquartered in Tampa, Florida.

OGEN Stock Price History

OGEN Stock News Headlines

StockNews.com Begins Coverage on Oragenics (NYSE:OGEN)
Trump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absolute
Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.
Oragenics, Inc. Announces Closing of Public Offering
Oragenics, Inc. Announces Pricing of Public Offering
Oragenics, Inc. Announces Proposed Public Offering
Trump Warns Gov. Can Confiscate Your Money. CBDC's give Gov. absolute
Donald Trump once again sounded the alarm against Fed-controlled digital currencies (CBDCs). If these plans are implemented, it could mean the end of America as we know it.
Oragenics, Inc. (OGEN)
See More Headlines
Receive OGEN Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for Oragenics and its competitors with MarketBeat's FREE daily newsletter.

Company Calendar

Last Earnings
5/15/2024
Today
7/23/2024
Fiscal Year End
12/31/2024

Industry, Sector and Symbol

Sector
Medical
Industry
Pharmaceutical preparations
Sub-Industry
Pharmaceutical Products
Employees
5
Year Founded
N/A

Profitability

Net Income
$-20,660,000.00
Pretax Margin
-96,485.71%

Debt

Sales & Book Value

Annual Sales
$40,000.00
Book Value
$0.61 per share

Miscellaneous

Free Float
3,379,000
Market Cap
$4.66 million
Optionable
N/A
Beta
0.50
7 Stocks That Could Be Bigger Than Tesla, Nvidia, and Google Cover

Growth stocks offer a lot of bang for your buck, and we've got the next upcoming superstars to strongly consider for your portfolio.

Get This Free Report

Key Executives

  • Mr. Charles L. Pope CPA (Age 72)
    Executive Chairman
    Comp: $112.5k
  • Mr. Joseph Michael Redmond (Age 63)
    President & Interim Principal Executive Officer
  • Ms. Janet Huffman (Age 52)
    CFO, Secretary & Treasurer
    Comp: $314.9k
  • Dr. James P. Kelly M.A.
    M.D., Chief Medical Officer & Member of Scientific Advisor

OGEN Stock Analysis - Frequently Asked Questions

How have OGEN shares performed this year?

Oragenics' stock was trading at $6.1382 at the beginning of the year. Since then, OGEN shares have decreased by 82.6% and is now trading at $1.0650.
View the best growth stocks for 2024 here
.

How were Oragenics' earnings last quarter?

Oragenics, Inc. (NYSE:OGEN) issued its earnings results on Wednesday, May, 15th. The company reported ($0.70) earnings per share (EPS) for the quarter.

When did Oragenics' stock split?

Oragenics's stock reverse split before market open on Monday, January 23rd 2023. The 1-60 reverse split was announced on Monday, January 23rd 2023. The number of shares owned by shareholders was adjusted after the closing bell on Monday, January 23rd 2023. An investor that had 100 shares of stock prior to the reverse split would have 2 shares after the split.

How do I buy shares of Oragenics?

Shares of OGEN stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.
Compare Top Brokerages Here.

What other stocks do shareholders of Oragenics own?

Based on aggregate information from My MarketBeat watchlists, some other companies that Oragenics investors own include Yunji (YJ), MFA Financial (MFA) and

This page (NYSE:OGEN) was last updated on 7/23/2024 by MarketBeat.com Staff

From Our Partners